|
Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS Clinical research trials and Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS. Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS clinical trial. Human subjects often receive the most effective healthcare possible for their Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS  Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS
Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS
For Condition: Obesity,Coronary Disease,Heart Diseases,Cardiovascular Diseases
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To conduct a genetic epidemiologic study of the coronary heart disease (CHD) risk factors of blood lipids and obesity in Black and white girls who participated in the NHLBI-supported National Growth and Health Study (NGHS). The study was ancillary to NGHS.
Details: BACKGROUND: The National Growth and Health Study, NGHS, was an epidemiologic study of 2,379 black and white girls, ages 9-10 years at entry, who were followed annually. The ancillary study had the potential for identifying those genes involved in determining Black/white differences in lipid metabolism and obesity. This was an exciting area in which there was virtually no available information. Finally, the study permitted an examination of the effects of gene variation on changes in quantitative levels of blood lipids as well as in body fat during different stages of pubescence since the NGHS protocol included annual anthropometric and maturation assessments and biannual blood lipid determinations along with extensive environmental measures which included dietary, household, and psychosocial information. The study was unique because of the rare opportunity to do genetic analyses in a large cohort of two ethnic groups of children on whom a very rich data base was available. DESIGN NARRATIVE: The study was an independent research project ancillary to the NGHS and utilized the extensive biological and environmental information available from the NGHS core data base. Blood samples were obtained from 1,133 girls seen at their followup examinations in Year 7 in order to determine genotypes at those loci known to be implicated in lipid metabolism and obesity. Both protein [apolipoproteins C-II, D, and E and LP(a)] and DNA [apolipoprotein B, lipoprotein lipase (LPL), and LDL receptor] were analyzed. The distribution of genetic variation within each ethnic group was determined. At each candidate gene locus, the genotype effects were estimated on quantitative level of apolipoproteins and lipoproteins, and also on the degree and distribution of body fat after adjusting for concomitant variables (such as age, biologic maturation stage adiposity) within each ethnic group. By comparing the frequencies of genotypes at candidate loci, their allelic effects were assessed as well as their impact on blood lipids and obesity development in Black and white females.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Female
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
SueKimm, , University of Pittsburgh
Additional Information:
Study ID Numbers: 4212;
Study Start Date: January 1993
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005345
Other Obesity Studies:
1. Framingham Cycle V Offspring-Spouse Nutrition Studies
2. Honolulu Heart Program
3. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
4. Prevalence of Asymptomatic Ventricular Dysfunction
5. Program on Surgical Control of Hyperlipidemias (POSCH)
Related Studies:
Other Obesity Clinical Trials
Other Clinical Trials
Other Clinical Trials
Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS
|
|
|
|
|
|
|
|
